[{"address1": "Clarence Thomas Building", "address2": "P.O. Box 4649 Road Town", "city": "Tortola", "zip": "VG1110", "country": "British Virgin Islands", "phone": "203 221 7378", "website": "https://www.portagebiotech.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Portage Biotech Inc., a clinical stage immune-oncology company, engages in the research and develops pharmaceutical and biotechnology products. Its product pipeline includes PORT-2 for treatment of refractory NSCLC, melanoma, and refractory melanoma that is in phase I and phase II clinical trials; PORT-3, for treatment of solid tumors, which is in phase I clinical trials; PORT-6, an A2AR inhibitor to treat A2A & A2B high solid tumors that is in phase Ia clinical trials; PORT-7, an A2AR inhibitor to treat A2A & A2B high solid tumors that is in phase Ib clinical trials; PORT-1, an intratumoral amphiphilic solutions for treatment of advanced soft tissue sarcoma, which is in phase 3 clinical trials; PORT-4, a nanolipogel co-formulations to treat of solid tumors that is in preclinical trials; and PORT-5, a VLP-STING to treat of solid tumors that is in preclinical trials. The company is based in Tortola, British Virgin Islands.", "fullTimeEmployees": 7, "companyOfficers": [{"maxAge": 1, "name": "Dr. Ian B. Walters M.B.A., M.D.", "age": 55, "title": "CEO & Chairman of Board", "yearBorn": 1968, "fiscalYear": 2023, "totalPay": 967651, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Robert A. Kramer Ph.D.", "title": "Chief Scientific Officer", "fiscalYear": 2023, "totalPay": 310157, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Brian  Wiley", "age": 55, "title": "Chief Business Officer", "yearBorn": 1968, "fiscalYear": 2023, "totalPay": 220688, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Justin  Fairchild", "title": "Vice President of Development", "fiscalYear": 2023, "totalPay": 283831, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Joseph  Ciavarella", "title": "Chief Accounting Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 0.278, "open": 0.28, "dayLow": 0.2758, "dayHigh": 0.35, "regularMarketPreviousClose": 0.278, "regularMarketOpen": 0.28, "regularMarketDayLow": 0.2758, "regularMarketDayHigh": 0.35, "beta": 99.752, "forwardPE": -0.57153845, "volume": 408097, "regularMarketVolume": 408097, "averageVolume": 94290, "averageVolume10days": 244830, "averageDailyVolume10Day": 244830, "bid": 0.2956, "bidSize": 100, "marketCap": 5879923, "fiftyTwoWeekLow": 0.2, "fiftyTwoWeekHigh": 4.4, "fiftyDayAverage": 0.5176, "twoHundredDayAverage": 1.622825, "currency": "USD", "enterpriseValue": 144920, "floatShares": 10212306, "sharesOutstanding": 19784400, "sharesShort": 6448, "sharesShortPriorMonth": 100205, "sharesShortPreviousMonthDate": 1709164800, "dateShortInterest": 1711584000, "sharesPercentSharesOut": 0.00029999999, "heldPercentInsiders": 0.38824, "heldPercentInstitutions": 0.11612, "shortRatio": 0.11, "shortPercentOfFloat": 0.0005, "bookValue": 1.618, "priceToBook": 0.18368356, "lastFiscalYearEnd": 1680220800, "nextFiscalYearEnd": 1711843200, "mostRecentQuarter": 1703980800, "netIncomeToCommon": -144898000, "trailingEps": -8.52, "forwardEps": -0.52, "enterpriseToEbitda": -0.008, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "PRTG", "underlyingSymbol": "PRTG", "shortName": "Portage Biotech Inc.", "longName": "Portage Biotech Inc.", "firstTradeDateEpochUtc": 1009981800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "c85b618a-5b14-3e35-9d8d-d4e5ddb2236b", "gmtOffSetMilliseconds": -14400000, "currentPrice": 0.2972, "targetHighPrice": 7.0, "targetLowPrice": 7.0, "targetMeanPrice": 7.0, "targetMedianPrice": 7.0, "recommendationMean": 3.0, "recommendationKey": "hold", "numberOfAnalystOpinions": 1, "totalCash": 5341000, "totalCashPerShare": 0.27, "ebitda": -18928000, "totalDebt": 275000, "quickRatio": 1.993, "currentRatio": 2.775, "debtToEquity": 0.878, "returnOnAssets": -0.0913, "returnOnEquity": -1.4519099, "freeCashflow": -8471250, "operatingCashflow": -15857000, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-04-23"}]